Back
LENZ Therapeutics, Inc. Stock Predictions
Share Price Moved. Momentum Hasn't Slowed.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi
Sell
6
LENZ
LENZ Therapeutics, Inc.
Last Price:
$18.01
Seasonality Move:
-5.91%
7 Day Trial
ALL ACCESS PASS
$
7
14K Investors Got In Earlier. You Still Can.
DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radiLENZ Therapeutics, Inc. Stock Forecast
-
Over the next 52 weeks, LENZ Therapeutics, Inc. has on average historically fallen by 12.8% based on the past 4 years of stock performance.
-
LENZ Therapeutics, Inc. has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
-
Is LENZ Therapeutics, Inc. Stock Undervalued?The current LENZ Therapeutics, Inc. [LENZ] share price is $18.00. The Score for LENZ is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.
-
LENZ is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
Will LENZ Therapeutics, Inc. Stock Go Up Next Year?
-
Over the next 52 weeks, LENZ Therapeutics, Inc. has on average historically fallen by 12.8% based on the past 4 years of stock performance.
LENZ Therapeutics, Inc. Stock Rating
Sell
6
LENZ Therapeutics, Inc. (LENZ)
is a Sell
Is LENZ Therapeutics, Inc. overpriced?
-
LENZ Therapeutics, Inc. has fallen lower in 3 of those 4 years over the subsequent 52-week period, corresponding to a historical accuracy of 75%
LENZ Therapeutics, Inc. Stock Price History
Stock Information
Stock Info
Exchange:
NASDAQ
Country:
United States
Industry:
Pharmaceuticals
Sector:
Health Care
Type:
stock
Website:
lenz-tx.com
52-Week Data
52-Week High:
50.40
52-Week Low:
15.70
Prediction Charts
Market Cap:
563.2M
Price in USD:
18.00
Volume:
1.1M
Beta:
0.47
Technical Analysis
SMA50:
28.29
SMA100:
34.13
SMA200:
31.08
52-Wk Change:
-40.55%
Stock Predictions
-
Is LENZ Therapeutics, Inc. stock public?Yes, LENZ Therapeutics, Inc. is a publicly traded company.
-
What is the LENZ Therapeutics, Inc. stock quote today?The LENZ Therapeutics, Inc. stock price is 18.00 USD today.
-
How to buy LENZ Therapeutics, Inc. stock online?You can buy LENZ Therapeutics, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.
14-Day Historical Data
| Date | Opening | Closing | Minimum | Maximum |
|---|---|---|---|---|
| Dec-2 | 30.13 | 27.31 | 30.78 | 27.07 |
| Dec-3 | 27.63 | 28.00 | 28.76 | 27.60 |
| Dec-4 | 27.88 | 27.90 | 29.02 | 27.65 |
| Dec-5 | 27.70 | 26.72 | 28.11 | 26.65 |
| Dec-8 | 26.94 | 26.71 | 27.84 | 26.03 |
| Dec-9 | 26.71 | 26.45 | 27.16 | 25.32 |
| Dec-10 | 26.36 | 25.04 | 26.66 | 24.77 |
| Dec-11 | 24.97 | 24.50 | 25.49 | 24.02 |
| Dec-12 | 24.66 | 18.14 | 24.79 | 15.70 |
| Dec-15 | 19.38 | 17.08 | 19.62 | 16.63 |
| Dec-16 | 17.20 | 16.70 | 17.27 | 16.30 |
| Dec-17 | 16.70 | 16.37 | 17.64 | 16.33 |
| Dec-18 | 16.60 | 17.07 | 17.88 | 16.50 |
| Dec-19 | 17.18 | 18.00 | 18.47 | 17.18 |
LENZ Therapeutics, Inc. Earnings
LENZ Therapeutics, Inc. Earnings Report: Per Share LENZ Therapeutics, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.
LENZ Therapeutics, Inc. Forecast Revenue Growth
LENZ Therapeutics, Inc. Stock Analysis: Historical quarterly revenues per share for LENZ Therapeutics, Inc. and historical quarterly revenue growth:
-
Analysts estimate an earnings decrease this quarter of $0.12 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.84 per share, and a decrease next year of $0.24 per share.
* LENZ Therapeutics, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.